Last reviewed · How we verify
NCT05006001
Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients
trial testing Colchicine and NSAID in Renal Impairment in 2,000 participants. Status unknown.
31 December 2019
Quick facts
| Lead sponsor | En Chu Kong Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 1 January 2012 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 December 2024 |
Drugs / interventions tested
- Colchicine and NSAID — full drug profile →
Conditions studied
- Renal Impairment — all drugs for Renal Impairment →
- Gout — all drugs for Gout →
- Colchicine Adverse Reaction — all drugs for Colchicine Adverse Reaction →
- Nonsteroidals (NSAIDs)Toxicity — all drugs for Nonsteroidals (NSAIDs)Toxicity →
Sponsor
En Chu Kong Hospital
Who can join
Adults 20 to 100, any sex, with Renal Impairment or Gout. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Our findings are expected to provide real-world evidence of the renal-adverse effects of colchicine and NSAIDs combination therapy in patients with gout, which will guide healthcare professions in optimizing gout treatment regimens and evaluating risks of renal impairment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05006001
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Renal Impairment
Currently open trials in the same condition.
- NCT07348237 — A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006) · Phase 1 · recruiting
- NCT07315360 — A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function · Phase 1 · recruiting
- NCT07217886 — A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls · Phase 1 · recruiting
- NCT07154901 — Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD23 · Phase 1 · recruiting
- NCT07017933 — Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes · NA · recruiting
Other En Chu Kong Hospital trials
Trials by the same sponsor.
- NCT06850311 — Herbal Ointment in Treating Atopic Dermatitis Topically · Phase 2, PHASE3 · recruiting
- NCT05455307 — Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture · NA · recruiting
- NCT05832905 — Mobile-assisted Case Management for Panic Disorder · completed
- NCT04250090 — Post-Marketing Follow-Up of Long-term Type Ureteral Stent Set · unknown
- NCT04423445 — Laser Acupuncture and Acupressure for Low Back Pain · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05006001 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by En Chu Kong Hospital
- Last refreshed: 16 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05006001.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing